Providence Capital Advisors, LLC Accelerate Diagnostics, Inc Transaction History

Providence Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	BUY	$0.46 - $0.77 $6 - $11	15 Added 44.12%	49 $0
Q1 2023 May 17, 2023	SELL	$0.46 - $0.77 $7,236 - $12,113	-15,732 Reduced 99.78%	34 $0
Q1 2023 May 10, 2023	BUY	$0.46 - $0.77 $7,229 - $12,102	15,717 Added 32075.51%	15,766 $11,000
Q4 2017 Feb 12, 2018	BUY	$18.0 - $30.0 $882 - $1,470	49	49 $1,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Providence Capital Advisors, LLC with notifications on news.